Published by Alexander Bueso on 17th April 2022
(Sharecast News) - The Financial Mail on Sunday's Midas column recommended shares of Impact Healthcare, as 'a long-term buy', touting the company's long-term growth prospects, dividend yield of over 5.0% and management's attention to detail which they surmised was paying off.
URL: http://www.digitallook.com/dl/news/story/32610111/...